INTRODUCTION {#sec1-1}
============

Renal leiomyosarcoma (LMS) is a rare form of aggressive renal cell cancer, which comprises approximately 1--3% of all adult malignant renal neoplasms arising from the renal capsule, renal pelvis or the vessel walls.\[[@CIT1]\] They account for more than half of all the renal sarcomas.\[[@CIT2]‐[@CIT5]\] Most renal LMSs have conventionally been managed by radical nephrectomy with or without adjuvant radiotherapy and or chemotherapy. We report and describe one such case of capsular LMS that had encased the infra-hepatic segment of inferior vena cava (IVC), which was managed successfully by radical nephrectomy and postoperative adjuvant chemotherapy. The literature regarding the incidence, presentation, diagnosis and prognosis of these rare malignant renal neoplasms has been reviewed.

CASE REPORT {#sec1-2}
===========

A 50-year-old woman presented with a painful palpable right flank mass of six months duration. Ultrasonography revealed an irregular echogenic right kidney with a 60 × 74 mm homogenous mass lesion in the cortex of right kidney adherent to the liver and gallstones. Computerized tomography confirmed a large homogenous mass lesion involving the right kidney, encasing the infra-hepatic segment of the IVC closely abutting the liver \[[Figure 1a](#F0001){ref-type="fig"}\]. Metastatic work-up confirmed a localized renal mass. On exploration, the right renal mass was found to be adherent to and encasing a 5 cm length of infra-hepatic IVC \[[Figure 1b](#F0001){ref-type="fig"}\]. Right radical nephrectomy with excision and repair of the involved anterior wall of IVC was performed \[[Figure 1c](#F0001){ref-type="fig"}\]. There was no IVC tumor thrombus or hepatic involvement. Gross tumor \[[Figure 1d](#F0001){ref-type="fig"}\] and histopathology revealed right renal capsular LMS involving the renal capsule and pelvis, encircling the renal hilar vessels. The wall of the IVC was not grossly involved by the tumor and the ureter was also free. The H and E stained slide showed a uniform pattern of interlacing closely packed spindle cells on low power (10× - [Figure 1e](#F0001){ref-type="fig"}) with pleomorphic hyperchromatic elongated nuclei amidst an eosinophilic cytoplasm (HP-40× - [Figure 1f](#F0001){ref-type="fig"}), which suggested LMS. Immunohistochemistry revealed a negative (HMB-45 - [Figure 1g](#F0001){ref-type="fig"}) and cytokeratin (CK - [Figure 1h](#F0001){ref-type="fig"}) staining and an intensely positive cytoplasmic staining for smooth muscle actin (SMA - [Figure 1i](#F0001){ref-type="fig"}), confirming the diagnosis of LMS. The patient was referred for adjuvant chemotherapy and radiotherapy. At nine months of follow-up, the lady continued to be free from clinical signs of the disease.

![a) A panel figure showing the large right renal tumor abutting the IVC (Figure 1a) with the intraoperative view showing the wedge excision of the IVC (Figure 1b) with its repair completed (Figure 1c) and the gross tumor on cut section (Figure 1d). An H and E stained slide showing a monotonous population of spindle cells on low power (Figure 1e) with elongated pleomorphic nuclei in an eosinophilic cytoplasm on high power (Figure 1f). Immuno-histochemical staining with antibodies to cytokeratin (-CK, Figure 1g), HMB-45 (Figure 1h) and smooth muscle actin (+SMA, Figure 1i)](UA-2-36-g001){#F0001}

DISCUSSION {#sec1-3}
==========

Transitional cell carcinomas continue to be the commonest histological variety of renal pelvic neoplasms, followed by renal sarcomas. Renal sarcomas also remain a diagnostic rarity with renal LMS being most commonly reported and encountered subtype of renal sarcoma worldwide.\[[@CIT3]\] Renal pelvic LMS are uncommonly reported with only four out of 30 cases\[[@CIT3]‐[@CIT5]\] of renal LMS being published and reported in the English literature to date \[[Table 1](#T0001){ref-type="table"}\].

###### 

The salient features of renal leiomyosarcomas reported to date

  Author                                                   No.   Presentation                                            Management                       FU
  -------------------------------------------------------- ----- ------------------------------------------------------- -------------------------------- -------------------
  Demir *et al*. 2007                                      1     Flank mass, pain, hematuria                             NSS                              3 yrs
  Sharma *et al*. 2007                                     1     Left flank pain, capsular LMS                           RN, CT, SWRT                     6½ yrs
  Kartsanis *et al*. 2006                                  1     Asymptomatic gross hematuria, pelvic LMS                RNUT, no adjuvant therapy        3 yrs
  Cocuzza *et al*. 2005                                    1     Hypertension investigation                              NSS (PN)                         \-
  Peyromaure *et al*. 2005                                 1     Pelvic LMS                                              \-                               \-
  Grasso *et al*. 2004                                     1     Spontaneous rupture, flank pain, perirenal hemorrhage   RN                               \-
  Deyrup *et al*. 2004                                     10    SMA, desmin, calponin (+)                               Int-high grade, poor prognosis   Mets (6) Recc (2)
  Moazzam *et al*. 2002                                    1     Spontaneous rupture                                     RN+splenectomy, high grade       \-
  Moudouni *et al*. 2001                                   1     Pelvic LMS                                              Wide surgical excision           \-
  Dominici A *et al*. 2000                                 1     Cystic LMS                                              RN                               \-
  Kavantzas *et al*. 1999                                  3     Flank pain, hematuria                                   RN                               \-
  El Otmany *et al*. 1999                                  1     Flank pain                                              RN+CT                            Mets
  Rebassa *et al*. 1999                                    1     Pain, mass                                              RN+RT                            \-
  Virseda *et al*. 1998                                    1     Pain, mass                                              RN+CT                            \-
  Lacquaniti *et al*. 1998                                 2     Atypical clinical features                              NSS                              6 yrs
  Tamaki *et al*. 1994[\*](#T000F1){ref-type="table-fn"}   1     Pain, HDN, incidental tumor                             RN                               \-
  Davis *et al*. 1992                                      1     Pelvic LMS                                              RN+RT+CT                         1 yr

NSS - Nephron sparing surgery; RN - Radical nephrectomy; RNUT - Radical nephroureterectomy; HDN - hydronephrosis, PN - Partial nephrectomy; CT - Adjuvant chemotherapy; SWRT - Sandwich radiotherapy; FU - Followup

Third case with 75 cases of LMS reported in Japanese literature

Renal LMS usually arise from renal capsule, renal pelvis or renal vessel smooth muscle fibers. It has been speculated though not proven that renal LMS arise from the renal capsule. They commonly present with flank pain and mass with or without hematuria. Occasionally they may present with spontaneous rupture and severe peri-renal hemorrhage. The diagnosis of LMS is generally suspected on H and E stained slides showing a monotonous population of spindle cells; however, this needs to be distinguished from the renal sarcoma and melanoma. Reliable differentiation from a sarcoma can be confirmed by immunohistochemistry (negative for antibodies to CK and HMB-45 and positive for antibodies to desmin and SMA; thereby indicating a mesenchymal neoplasm arising from muscle tissue), which also differentiates LMS from primary pure renal sarcomas, angiomyolipomas and nerve sheath cell tumors.

The reported comparative survival of renal LMS is about 25% (5-year overall survival) to 60% (5-year cause-specific survival) with a median overall survival of 25 months. Recurrences and metastasis are common. Renal LMS should be treated as sarcoma using multimodality therapy so as to optimize survival and reduce tumor recurrence due to their overall poor prognosis. A review of similar cases of LMS \[see [Table 1](#T0001){ref-type="table"}\] shows that in summary, renal LMS are aggressive tumors with poor prognosis. Radical nephrectomy has been the usual treatment of choice except for isolated cases presenting as localized small, polar renal nodules where a partial nephrectomy may suffice. A combination of aggressive radical surgical ablation with a selective anti-tumor signal blocking chemotherapy seems to be the preferred approach for managing most LMS.

The present report highlights the importance of deploying immunostaining in order to precisely define the exact histological type of renal sarcoma being encountered. This helps the treating urologist and surgeon in providing an accurate patient prognosis, with proper follow-up counseling and management.
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